Literature DB >> 34237771

After the pandemic: perspectives on the future trajectory of COVID-19.

Amalio Telenti1,2, Ann Arvin3, Lawrence Corey4, Davide Corti5, Michael S Diamond6, Adolfo García-Sastre7,8,9,10, Robert F Garry11, Edward C Holmes12, Phil Pang13, Herbert W Virgin14,15,16.   

Abstract

There is a realistic expectation that the global effort in vaccination will bring the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic under control. Nonetheless, uncertainties remain about the type of long-term association the virus will establish with the human population, particularly whether the coronavirus disease 2019 (COVID-19) will become an endemic disease. Although the trajectory is difficult to predict, the conditions, concepts, and variables that influence this transition can be anticipated. Persistence of SARS-CoV-2 as an endemic virus, perhaps with seasonal epidemic peaks, may be fueled by pockets of susceptible individuals and waning immunity after infection or vaccination, changes in the virus through antigenic drift that diminish protection, and reentries from zoonotic reservoirs. Here, we review relevant observations from previous epidemics and discuss the potential evolution of SARS-CoV-2 as it adapts during persistent transmission in the presence of a level of population immunity. Lack of effective surveillance or adequate response could enable the emergence of new epidemic or pandemic patterns from an endemic infection of SARS-CoV-2. There are key pieces of data that are urgently needed in order to make good decisions. We outline these and propose a way forward.

Entities:  

Year:  2021        PMID: 34237771     DOI: 10.1038/s41586-021-03792-w

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  68 in total

1.  Pregnant at the start of the pandemic: a content analysis of COVID-19-related posts on online pregnancy discussion boards.

Authors:  Rebekah Choi; Ashwini Nagappan; Deena Kopyto; Anna Wexler
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-16       Impact factor: 3.105

Review 2.  Immune response in COVID-19: what is next?

Authors:  Qing Li; Ying Wang; Qiang Sun; Jasmin Knopf; Martin Herrmann; Liangyu Lin; Jingting Jiang; Changshun Shao; Peishan Li; Xiaozhou He; Fei Hua; Zubiao Niu; Chaobing Ma; Yichao Zhu; Giuseppe Ippolito; Mauro Piacentini; Jerome Estaquier; Sonia Melino; Felix Daniel Weiss; Emanuele Andreano; Eicke Latz; Joachim L Schultze; Rino Rappuoli; Alberto Mantovani; Tak Wah Mak; Gerry Melino; Yufang Shi
Journal:  Cell Death Differ       Date:  2022-05-17       Impact factor: 12.067

3.  Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program.

Authors:  Joice P Silva; Aline B de Lima; Luige B Alvim; Frederico S V Malta; Cristiane P T B Mendonça; Paula L C Fonseca; Filipe R R Moreira; Daniel C Queiroz; Jorge G G Ferreira; Alessandro C S Ferreira; Renan P Souza; Renato S Aguiar; Danielle A G Zauli
Journal:  Viruses       Date:  2022-04-20       Impact factor: 5.818

4.  From Pandemicity to Endemicity: The Journey of SARS-CoV-2.

Authors:  Jaffar A Al-Tawfiq; Dinh-Toi Chu; Van-Thuan Hoang; Ziad A Memish
Journal:  J Epidemiol Glob Health       Date:  2022-06

5.  Potential Use of Tea Tree Oil as a Disinfectant Agent against Coronaviruses: A Combined Experimental and Simulation Study.

Authors:  Alice Romeo; Federico Iacovelli; Carolina Scagnolari; Mirko Scordio; Federica Frasca; Roberta Condò; Serena Ammendola; Roberta Gaziano; Maurizio Anselmi; Maurizio Divizia; Mattia Falconi
Journal:  Molecules       Date:  2022-06-12       Impact factor: 4.927

Review 6.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

7.  Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil.

Authors:  Mariana Lourenço Freire; Lindicy Leidicy Alves; Carolina Senra de Souza; Juliana Wilke Saliba; Verônica Faria; Mariana Junqueira Pedras; Nara de Oliveira Carvalho; Gláucia Queiroz Andrade; Ana Rabello; Daniel Moreira Avelar; Gláucia Cota
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

Review 8.  Recent advances in small-molecular therapeutics for COVID-19.

Authors:  Lei Zhong; Zhipeng Zhao; Xuerun Peng; Jun Zou; Shengyong Yang
Journal:  Precis Clin Med       Date:  2022-09-24

Review 9.  Human genetic and immunological determinants of critical COVID-19 pneumonia.

Authors:  Qian Zhang; Paul Bastard; Aurélie Cobat; Jean-Laurent Casanova
Journal:  Nature       Date:  2022-01-28       Impact factor: 69.504

10.  Combining graph neural networks and spatio-temporal disease models to improve the prediction of weekly COVID-19 cases in Germany.

Authors:  Cornelius Fritz; Emilio Dorigatti; David Rügamer
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.